查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1878101

穿戴式註射器市场－2025-2030年预测

Wearable Injectors Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 114 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球穿戴式註射器市场预计将从 2025 年的 101.48 亿美元成长到 2030 年的 250.84 亿美元，预测期内复合年增长率为 19.84%。

穿戴式註射器代表了医疗药物输送系统的一项重大进步。这些装置也称为贴片帮浦或体表输送系统，直接佩戴在患者身上，旨在以可控、持续的方式输送药物。它们特别适用于需要大剂量、高黏度药物以及需要长期规律给药的治疗方案。透过减少多次且往往痛苦的手动注射，这些装置提供了一种便捷易用的替代方案，从而提高了患者的依从性和生活品质。

穿戴式註射器的主要提案在于其易于自我给药、最大限度减少对日常生活的干扰、提高剂量准确性以及预防针刺伤。此外，透过使患者能够在诊所外管理自身健康，可减少就诊次数，从而有助于降低整体医疗成本，并赋予患者更大的自主权来管理慢性疾病。

主要市场成长驱动因素

全球穿戴式註射器市场的主要成长要素是全球慢性（非传染性）疾病的日益普遍。癌症、心血管疾病、糖尿病和自体免疫疾病等疾病需要长期且频繁地用药。穿戴式註射器在有效控制这些疾病方面发挥着至关重要的作用。它们尤其适用于依规定间隔注射生物製药和其他复杂的治疗药物，从而避免过量或不足的用药。这些设备带来的便利性不仅改善了病患体验，还透过减少病患因注射而频繁前往医院的次数，显着节省了时间和成本。

随着疾病负担的加重，技术进步和意识提升预计也将推动市场成长。日益增强的健康意识和对治疗方案的广泛了解，正在推动对以患者为中心的先进医疗设备的需求。穿戴式註射器顺应了这一趋势，提供了一种隐密且易于操作的治疗方案。技术进步也透过高度自动化显着降低了製造成本，使企业能够实现规模经济。这种成本效益使製造商能够将资金重新投入研发，从而激发创新循环，最终推出更精密、更易于使用的医疗器材。

市场限制

儘管成长前景可观，但这些设备带来的环境问题仍是限制市场发展的主要因素。穿戴式註射器通常设计为一次性使用，且由塑胶零件构成。这些设备的大规模应用，加上不当的处置方式，会产生大量的塑胶废弃物。由于并非所有地区都有完善的医疗废弃物管理和回收系统，使用过的注射器若处理不当，可能会造成环境风险，因为塑胶需要相当长的时间才能分解。这种生态影响是产业必须透过永续设计和产品报废管理策略来应对的挑战。

主要市场趋势和竞争格局

穿戴式註射器市场活跃度较高，主要厂商纷纷透过策略联盟、收购和技术升级来巩固市场地位并拓展产品系列。一个显着的趋势是製药公司与专业医疗器材製造商之间的合作。这些合作旨在共同开发和生产整合式药物输送系统，例如 enFuse® 穿戴式註射器，该产品专注于透过便利的居家给药方式来改善患者体验。

各公司也正在透过将全面的人体工学融入其开发平台来增强其服务产品，这种方法确保设备对患者来说直观且安全，从而降低监管核准过程中的风险，并加快新组合产品的上市速度。

策略性收购也是市场格局的关键特征。主要企业正在收购拥有互补技术的公司，例如自动化胰岛素输注系统和药房自动化解决方案。这些收购旨在建构一个更全面的药物管理生态系统，涵盖从急诊护理到家庭护理的各个阶段，从而提高患者的用药依从性、安全性和整体治疗效果。先进系统的推出，例如与持续血糖监测仪整合的无管自动化胰岛素输注系统，代表持续创新，旨在提供无缝且有效的慢性病管理。

本报告的主要优势：

  • 深入分析：获得主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
  • 竞争格局：了解全球主要参与者的策略倡议，并了解透过正确的策略进入市场的机会。
  • 市场驱动因素与未来趋势：探讨影响市场的动态因素和关键趋势及其对未来市场发展的影响。
  • 可操作的建议：利用这些见解，在动态环境中做出策略决策，并开拓新的商机和收入来源。
  • 受众广泛：对Start-Ups、研究机构、顾问公司、中小企业和大型企业都很有用且经济实惠。

企业使用我们的报告做什么？

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围：

  • 2022年至2024年的历史数据和2025年至2030年的预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区分類的收入成长和预测评估，包括国家/地区
  • 公司概况（策略、产品、财务资讯、关键发展等）

穿戴式註射器市场细分：

  • 全球穿戴式註射器市场（按类型划分）
  • 体外註射器
  • 非体注射
  • 全球穿戴式註射器市场（依科技划分）
  • 马达驱动
  • 扩充电池
  • 弹簧型
  • 旋转泵型
  • 其他的
  • 全球穿戴式註射器市场按应用领域划分
  • 肿瘤学
  • 糖尿病
  • 心血管疾病
  • 自体免疫疾病
  • 其他的
  • 全球穿戴式註射器市场（按最终用户划分）
  • 医院和诊所
  • 门诊手术中心
  • 居家照护中心
  • 其他的
  • 全球穿戴式註射器市场（按地区划分）
  • 北美洲
  • 美国
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他的
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
  • 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他的
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
  • 其他的

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策与法规
  • 策略建议

第四章 技术展望

5. 全球穿戴式註射器市场（按类型划分）

  • 介绍
  • 体外註射器
  • 非体注射

6. 全球穿戴式註射器市场（依科技划分）

  • 介绍
  • 马达驱动
  • 扩充电池
  • 弹簧型
  • 旋转泵
  • 其他的

7. 全球穿戴式註射器市场（按应用划分）

  • 介绍
  • 肿瘤学
  • 糖尿病
  • 心血管疾病
  • 自体免疫疾病
  • 其他的

8. 全球穿戴式註射器市场（依最终用户划分）

  • 介绍
  • 医院和诊所
  • 门诊手术中心
  • 居家照护中心
  • 其他的

9. 全球穿戴式註射器市场（按地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第十章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十一章 公司简介

  • Medtronic
  • Amgen（Acquired by tenebio）
  • Ypsomed
  • Insulet Corporation
  • West Pharmaceutical Services
  • Becton Dickinson And Company
  • Enable Injections
  • United Therapeutics Corporation
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson

第十二章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061611830

The global wearable injectors market is projected to witness a CAGR of 19.84% during the forecast period to reach a total market size of US$25.084 billion by 2030, increasing from US$10.148 billion in 2025.

Wearable injectors represent a significant advancement in medical drug delivery systems. These devices, also known as patch pumps or on-body delivery systems, are designed to be attached directly to the patient to administer medication in a controlled and sustained manner. They are particularly suited for high-volume drugs, medications with high viscosities, and treatments that require regular administration over extended periods. By reducing the need for multiple, often painful manual injections, these devices offer a convenient and user-friendly alternative that enhances patient compliance and quality of life.

The core value proposition of wearable injectors includes ease of use for self-administration, minimal interference with daily activities, improved dose accuracy, and the prevention of needlestick injuries. Furthermore, by enabling patients to manage their treatments outside of clinical settings, these devices help reduce hospital and clinic visits, contributing to lower overall healthcare costs and providing greater autonomy to individuals managing chronic conditions.

Primary Market Growth Drivers

A primary driver for the global wearable injector market is the increasing prevalence of chronic, or non-communicable, diseases worldwide. Conditions such as cancer, cardiovascular diseases, diabetes, and autoimmune disorders require long-term, often frequent, drug administration. Wearable injectors play a crucial role in managing these diseases effectively. They are especially valuable for delivering biologics and other complex therapeutics at prescribed intervals, thereby eliminating the possibility of over- or under-dosing. The convenience they offer not only improves the patient experience but also generates significant time and cost savings by minimizing the need for frequent medical appointments solely for injections.

Concurrent with the rising disease burden, technological advancement and increasing patient awareness are also anticipated to propel market growth. As individuals become more health-conscious and informed about available treatment options, the demand for advanced, patient-centric medical devices rises. Wearable injectors align with this trend by offering discreet and manageable treatment solutions. Technological progress has also been instrumental in reducing manufacturing costs through advanced automation, enabling companies to achieve economies of scale. This cost efficiency allows manufacturers to reinvest in research and development, fostering a cycle of innovation that leads to more sophisticated and accessible devices.

Market Restraints

Despite the promising growth trajectory, a significant restraint on the market is the environmental concern associated with these devices. Wearable injectors are typically designed for single-use and are constructed with plastic components. The large-scale adoption of these devices, coupled with improper disposal practices, can lead to substantial plastic waste. Since not all regions possess robust medical waste management and recycling systems, the improper handling and disposal of used injectors can pose environmental hazards, as plastics take a considerable time to decompose. This ecological impact presents a challenge that the industry must address through sustainable design and end-of-life management strategies.

Key Market Developments and Competitive Landscape

The wearable injectors market is characterized by dynamic activity, with key players engaging in strategic partnerships, acquisitions, and technological enhancements to strengthen their market position and expand their product portfolios. A prominent trend involves collaborations between pharmaceutical companies and specialized device manufacturers. These partnerships aim to co-develop and manufacture integrated drug delivery systems, such as the enFuse(R) wearable injector, focusing on improving the patient experience through discreet, at-home administration.

Companies are also enhancing their service offerings by integrating comprehensive human factors engineering into their development platforms. This approach de-risks the regulatory approval process and accelerates time-to-market for new combination products by ensuring devices are intuitive and safe for patient use.

Strategic acquisitions are another key feature of the market landscape. Leading companies are acquiring firms with complementary technologies, such as automated insulin delivery systems or pharmacy automation solutions. These acquisitions are aimed at creating more comprehensive medication management ecosystems that span from acute care to home settings, improving medication adherence, patient safety, and overall outcomes. The introduction of advanced systems, including tubeless, automated insulin delivery systems integrated with continuous glucose monitors, exemplifies the ongoing innovation aimed at providing seamless and effective chronic disease management.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Wearable Injectors Market Segmentation:

  • GLOBAL WEARABLE INJECTORS MARKET BY TYPE
  • On-Body Injectors
  • Off-Body Injectors
  • GLOBAL WEARABLE INJECTORS MARKET BY TECHNOLOGY
  • Motor-driven
  • Expanding Battery
  • Spring-based
  • Rotary Pump
  • Others
  • GLOBAL WEARABLE INJECTORS MARKET BY APPLICATION
  • Oncology
  • Diabetes
  • Cardiovascular Disease
  • Autoimmune Disease
  • Others
  • GLOBAL WEARABLE INJECTORS MARKET BY END-USER
  • Hospitals and Clinics
  • Ambulatory Surgery Centres
  • Home Care Centres
  • Other
  • GLOBAL WEARABLE INJECTORS MARKET BY GEOGRAPHY
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL WEARABLE INJECTORS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. On-Body Injectors
  • 5.3. Off-Body Injectors

6. GLOBAL WEARABLE INJECTORS MARKET BY TECHNOLOGY

  • 6.1. Introduction
  • 6.2. Motor-driven
  • 6.3. Expanding Battery
  • 6.4. Spring-based
  • 6.5. Rotary Pump
  • 6.6. Others

7. GLOBAL WEARABLE INJECTORS MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Oncology
  • 7.3. Diabetes
  • 7.4. Cardiovascular Disease
  • 7.5. Autoimmune Disease
  • 7.6. Others

8. GLOBAL WEARABLE INJECTORS MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals and Clinics
  • 8.3. Ambulatory Surgery Centres
  • 8.4. Home Care Centres
  • 8.5. Other

9. GLOBAL WEARABLE INJECTORS MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Medtronic
  • 11.2. Amgen (Acquired by tenebio)
  • 11.3. Ypsomed
  • 11.4. Insulet Corporation
  • 11.5. West Pharmaceutical Services
  • 11.6. Becton Dickinson And Company
  • 11.7. Enable Injections
  • 11.8. United Therapeutics Corporation
  • 11.9. F. Hoffmann-La Roche AG
  • 11.10. Johnson & Johnson

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations